Wells Fargo
NEXI

Wells Fargo’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Wells Fargo’s Portfolio NEXI Stock Details NEXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7
Closed -$39 – 7647
2024
Q1 		$39 Buy
7
+2
+40% +$15 ﹤0.01% 6896
2023
Q4 		$11 Hold
5
– – ﹤0.01% 7374
2023
Q3 		$26 Sell
5
-1
-17% -$6 ﹤0.01% 7122
2023
Q2 		$39 Buy
6
+1
+20% +$9 ﹤0.01% 7121
2023
Q1 		$51 Hold
5
– – ﹤0.01% 7108
2022
Q4 		$30 Buy
5
+1
+25% +$12 ﹤0.01% 7176
2022
Q3 		$0 Buy
4
+2
+100% +$59 ﹤0.01% 7602
2022
Q2 		$0 Sell
2
-303
-99% -$18.8K ﹤0.01% 7713
2022
Q1 		$32K Sell
305
-95
-24% -$6.97K ﹤0.01% 5849
2021
Q4 		$46K Buy
400
+398
+19,900% +$95.6K ﹤0.01% 6010
2021
Q3 		$1K Sell
2
-292
-99% -$97.9K ﹤0.01% 6834
2021
Q2 		$120K Buy
294
+214
+268% +$98.6K ﹤0.01% 5232
2021
Q1 		$38K Buy
+80
New +$43.5K ﹤0.01% 5939

Other funds holding NEXI

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo's NEXI Position: Q2 2024 in Review

Wells Fargo sold out of NexImmune, Inc. Common Stock (NEXI) in Q2 2024, closing a stake of 7 shares — an estimated $39 sold.

Wells Fargo first reported a position in NEXI in Q1 2021 and held it in 13 quarters. The position peaked at $120K in Q2 2021. 13 funds tracked by Wall St. Rank hold NEXI as of Q2 2024.

  • Wells Fargo reported no remaining NexImmune, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 7 NexImmune, Inc. Common Stock shares in Q2 2024, an estimated $39.
  • Wells Fargo first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 13 quarters.
  • Wells Fargo's NexImmune, Inc. Common Stock position peaked at $120K in Q2 2021.
  • 13 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.